Marc Brisson is a full professor at Université Laval in the Faculty of Medicine, where he leads the Research Group in Mathematical Modeling and Health Economics of Infectious Diseases. He holds the Tier 1 Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Diseases. Brisson earned a BSc in Actuarial Science from 1992 to 1996, a certificate in Statistics in 1996, and an MSc in Epidemiology from 1996 to 2001, all from Université Laval. He completed a PhD in Health Economics from 1999 to 2004 at City University in London, England. His research specializations center on infectious disease epidemiology, mathematical modeling, and economic analysis, with a focus on HPV vaccination impacts and cervical cancer prevention strategies. Brisson has co-directed international studies, including two papers published in The Lancet in 2020 examining vaccination and screening effects on cervical cancer elimination. He has contributed to research showing substantial reductions in HPV infections and precancerous lesions through vaccination programs. Brisson's influence extends to global public health policy, informing efforts to eliminate cervical cancer as a public health problem. His academic appointments include full professor roles at Université Laval and visiting professor positions at institutions such as the Saw Swee Hock School of Public Health at the National University of Singapore. Key contributions include leadership in modeling studies that assess long-term population-level impacts of one-dose HPV vaccination and catch-up programs. Brisson maintains a strong publication record with highly cited work in infectious disease modeling and health economics, as evidenced by his Google Scholar profile. He participates in international research consortia and has been involved in press releases from Université Laval highlighting advancements in cervical cancer research.